Authored By: Sarah
10 Feb 2023

Amlodipine Besylate Market Share, Segments, Trends, Growth, and Geography- Analysis, and Forecast 2022-2026

The amlodipine besylate market share is forecast to reach USD 217.26 million, after growing at a CAGR of 3.6% during 2021-2026. The rising incidence of hypertension is analyzed to boost the amlodipine besylate market growth. Moreover, increasing usage of amlodipine besylate in various treatments is the major trend enhancing the overall market demand for amlodipine besylate during the forecast period.   

Get a snapshot of the amlodipine besylate market analysis: Unlock the Sample Report 

Browse Technavio's 116-page report and in-depth TOC on "Amlodipine Besylate Market by Application (High blood pressure and heart diseases) and Geography (North America, Europe, Asia, and the Rest of the World (ROW)).

View detailed Table of Contents Here:

Amlodipine Besylate Market Share, Segments, Trends, Growth, and Geography- Analysis, and Forecast 2022-2026


  • High blood pressure: The amlodipine besylate market share growth by the high blood pressure segment will be significant during the forecast period. A high blood pressure patient must continue taking amlodipine even if they feel well. Such medication for high blood pressure will drive the amlodipine besylate market growth.

  • Heart diseases


  • North America: 39% of market growth will develop from North America during the forecast period. Huge investments in the pharmaceutical business will facilitate the amlodipine besylate market growth in North America over the forecast period.

  • Europe 

  • Asia 

  • Rest of World (ROW) 

Key Takeaways: 

  • The amlodipine besylate market size will witness a YOY Growth Rate of 3.0% in 2022.  

  • The side effects on human health will be a major challenge for the amlodipine besylate market during the forecast period. 

  • Major key amlodipine besylate market players include: Amsal Chem Pvt. Ltd., Aurobindo Pharma Ltd., Cadila Pharmaceuticals Ltd., CENTURY PHARMACEUTICALS Ltd., Cipla Ltd., Dr. Reddys Laboratories Ltd., MOEHS IBERICA SL, Rakshit Drugs Pvt. Ltd., VPL Chemicals Pvt. Ltd., Changzhou Yabang Pharmaceutical Co. Ltd., Pfizer Inc., Apotex Inc., Lupin Ltd., Strides Pharma Science Ltd, Teva Pharmaceutical Industries Ltd., Chartwell Pharmaceuticals LLC, Synthon International Holding BV, Sun Pharmaceutical Industries Ltd., Zydus Lifesciences Ltd., and Orbion Pharmaceuticals Pvt. Ltd.  

  • The report illustrates the lifecycle of the market, focusing on the adoption rates of the major regions such as North America, Europe, Asia, and Rest of World (ROW). 

Download the PDF sample report for highlights on the market size, growth momentum, regional growth opportunities, vendor analysis, and other factors influencing the market growth

Key data covered in the Amlodipine Besylate Market report 

  • Precise market size estimation during the forecast period 2022-2026.  

  • CAGR of the amlodipine besylate market forecast during 2022-2026.  

  • Market-level data on units, average selling prices, and values of the amlodipine besylate market share.  

  • Prediction of the upcoming trends, drivers, and factors that challenge the growth of the amlodipine besylate market.  

  • Amlodipine besylate industry growth across North America, Europe, Asia, and Rest of World (ROW). 

Read News Read Less
Interested in this report?
Get your sample now!